Phase 1 Study of Mesothelin-ADC

Summary

The purpose of this study is to assess the safety and tolerability of Mesothelin-ADC in subjects with advanced and/or metastatic solid tumors.

Timeline

Start

2016-10-14

Primary completion

2017-09-06

Completion

2017-09-06

Drugs

Indications